The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Complementary and alternative medicine (CAM) use in lung cancer: The impact of control.
Joshua Bauml
No relevant relationships to disclose
Corey J. Langer
No relevant relationships to disclose
Tracey L. Evans
No relevant relationships to disclose
Sheila N. Garland
No relevant relationships to disclose
Krupali Desai
No relevant relationships to disclose
Jun J Mao
No relevant relationships to disclose